Bruker Corporation vs. 10x Genomics, Inc. Class A Common Stock
Bruker Corporation (BRKR) comes out ahead, leading on 6 of 8 compared factors.
Size & Scale
| BRKR | TXG | |
|---|---|---|
| Market Cap | $9.61 billion | $10.03 billion |
| Revenue (TTM) | $3.50 billion | $616.91 million |
| Net Income (TTM) | $-64,500,000 | $-75,125,000 |
BRKR leads on 2 of 3 size & scale factors.
Valuation
| BRKR | TXG | |
|---|---|---|
| Price / Book | 4.00 | 12.15 |
| Price / Sales | 2.74 | 16.26 |
BRKR leads on 2 of 2 valuation factors.
Profitability
| BRKR | TXG | |
|---|---|---|
| Net Margin | -1.84% | -12.18% |
| Return on Equity | -2.69% | -9.10% |
BRKR leads on 2 of 2 profitability factors.
Dividend
| BRKR | TXG | |
|---|---|---|
| Dividend Yield | 0.33% | — |
BRKR and TXG split the dividend factors evenly.
Risk & Sentiment
| BRKR | TXG | |
|---|---|---|
| Short Interest | 1.53% | 0.42% |
TXG leads on 1 of 1 risk & sentiment factors.
Dig deeper: BRKR overview, BRKR financials, TXG overview, TXG financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.